These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
371 related items for PubMed ID: 23592708
1. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. Gheorghiade M, Fonarow GC, van Veldhuisen DJ, Cleland JG, Butler J, Epstein AE, Patel K, Aban IB, Aronow WS, Anker SD, Ahmed A. Eur Heart J; 2013 May; 34(20):1489-97. PubMed ID: 23592708 [Abstract] [Full Text] [Related]
7. Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation. Shariff N, Desai RV, Patel K, Ahmed MI, Fonarow GC, Rich MW, Aban IB, Banach M, Love TE, White M, Aronow WS, Epstein AE, Ahmed A. Am J Med; 2013 Oct; 126(10):887-93. PubMed ID: 24054956 [Abstract] [Full Text] [Related]
13. Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial. Botis M, Kartas A, Samaras A, Akrivos E, Vrana E, Liampas E, Papazoglou AS, Moysidis DV, Papanastasiou A, Baroutidou A, Karvounis H, Tzikas A, Parissis J, Drakos SG, Giannakoulas G. Hellenic J Cardiol; 2022 Oct; 68():25-32. PubMed ID: 36037999 [Abstract] [Full Text] [Related]
14. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breithardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowitz SD, Nessel CC, Fox KA, Califf RM, Piccini JP, Patel MR, ROCKET AF Steering Committee and Investigators. Lancet; 2015 Jun 13; 385(9985):2363-70. PubMed ID: 25749644 [Abstract] [Full Text] [Related]
15. Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation. Chiang JY, Chen PC, Yang YH, Chang CH, Chu FY, Chen JJ, Wu CK, Hwang JJ, Chiang FT, Lin LY, Lin JL. Sci Rep; 2020 Mar 05; 10(1):4101. PubMed ID: 32139765 [Abstract] [Full Text] [Related]
17. A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study. Ahmed MI, White M, Ekundayo OJ, Love TE, Aban I, Liu B, Aronow WS, Ahmed A. Eur Heart J; 2009 Aug 05; 30(16):2029-37. PubMed ID: 19531579 [Abstract] [Full Text] [Related]
18. Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation. Okin PM, Hille DA, Wachtell K, Kjeldsen SE, Boman K, Dahlöf B, Devereux RB. J Hypertens; 2015 Jul 05; 33(7):1480-6. PubMed ID: 25799208 [Abstract] [Full Text] [Related]